No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleonly males |
244368 |
2. Check conditions
|
244216 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
74 |
4. Check minimum number of eventsNone |
74 |
5. Include endpointsNone |
74 |
6. Filter based on genotype QC (FinnGen only) |
64 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
- Parent code in ICD-10
- D07
- Name in latin
- Carcinoma in situ vesicae urinariae
Carcinoma in situ of penis
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 64 | - | 64 |
| Unadjusted period prevalence (%) | 0.03 | - | 0.03 |
| Median age at first event (years) | 66.90 | - | 66.90 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 68
- Matched controls
- 680
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D07.4
ICD-10 Finland
Carcinoma in situ: Penis
+∞
72.3
56
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
11.8
20.2
26
34
KGB00
NOMESCO Finland
Biopsy of penis
86.6
13.1
14
*
N48.1
ICD-10 Finland
Balanoposthitis
21.7
12.5
18
11
KGD10
NOMESCO Finland
Destruction of lesion of penis
115.4
9.7
10
*
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
+∞
9.6
9
*
D06BB10
ATC
imiquimod; topical
12.7
9.1
16
16
KGH10
NOMESCO Finland
Operation for phimosis
12.5
8.6
15
15
L43.8
ICD-10 Finland
Other lichen planus
+∞
8.5
8
*
E0000UV, ,
ATC
4.3
8.1
40
170
C60.1
ICD-10 Finland
Malignant neoplasm: Glans penis
89.4
7.6
8
*
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
4.9
7.5
20
53
A63.0
ICD-10 Finland
Anogenital (venereal) warts
34.0
7.3
9
*
Z2221
NOMESCO Finland
Medical doctor
4.0
7.1
29
106
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
19.2
7.0
10
6
WX320
NOMESCO Finland
Spinalanesthesy
3.8
6.5
29
112
8070/2-C60.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of penis, NOS
+∞
6.3
6
*
J02AC01
ATC
fluconazole; systemic
4.1
6.3
22
71
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
16
51
3.79
4.56
2.8
2.3
33.55
26.02
u/l
0.76
11
40
9
15
6.73
3.96
1.4
1.2
—
—
—
0
0
34
190
2.58
3.58
5.9
3.0
0.26
0.37
e6/l
0.27
27
135
13
41
3.67
3.28
2.5
1.6
—
—
—
0
0
11
30
4.17
3.26
1.3
2.1
—
—
—
0
0
30
164
2.48
3.24
2.7
2.0
3.47
2.70
mg/l
0.69
22
153
39
241
2.45
3.22
6.2
3.5
—
—
—
0
0
13
47
3.18
3.01
1.9
1.5
—
—
—
0
0
6
9
7.18
2.93
1.3
1.6
—
—
—
0
0
23
116
2.49
2.90
4.6
2.6
0.18
0.51
e6/l
1.41
13
64
22
113
2.40
2.64
4.8
2.8
0.69
0.38
e6/l
0.24
13
61
27
152
2.29
2.64
3.4
3.0
—
—
—
0
0
10
32
3.48
2.56
3.8
3.4
—
—
—
0
0
10
32
3.48
2.56
1.6
2.3
—
—
—
0
0
7
17
4.46
2.43
1.3
1.2
—
—
—
0
0
7
17
4.46
2.43
1.3
1.2
—
—
—
0
0
23
128
2.20
2.26
3.0
1.8
—
—
—
0
0
43
308
2.08
2.16
17.7
11.1
1.20
1.19
mmol/l
0.19
37
275
39
271
2.03
2.11
3.7
3.6
—
—
estimate
—
0
0
18
94
2.24
2.04
2.2
1.6
—
—
—
0
0
7
21
3.59
2.02
1.4
1.4
—
—
—
0
0
9
33
2.98
2.02
10.9
28.6
16.07
14.89
%
—
9
33
38
266
1.97
1.97
2.9
2.1
100.84
91.13
pmol/l
0.53
23
151
42
309
1.94
1.84
4.4
3.5
0.00
0.00
estimate
—
7
69
6
18
3.55
1.79
1.7
1.6
—
—
—
0
0
45
342
1.93
1.75
20.6
12.4
4.19
4.35
e9/l
0.12
39
301
13
63
2.31
1.73
7.6
9.5
1.22
1.39
mmol/l
0.37
13
63
8
31
2.79
1.72
3.9
2.7
1064.88
573.08
ug/l
—
8
31
7
25
3.00
1.70
2.3
1.6
—
—
—
0
0
7
25
3.00
1.70
1.3
1.3
—
—
—
0
0
11
50
2.43
1.67
5.5
8.3
23.03
24.81
mmol/l
0.67
11
50
42
316
1.86
1.65
4.4
3.5
0.00
4.62
estimate
—
7
65
10
44
2.49
1.64
2.1
2.2
91.90
216.24
ng/l
—
10
38
42
317
1.85
1.62
4.5
3.4
0.00
0.00
estimate
—
7
71
6
21
3.03
1.54
2.5
1.5
191.33
218.48
%
—
6
21
40
302
1.79
1.50
3.6
2.5
—
—
—
0
0
7
28
2.67
1.49
2.0
1.5
—
—
—
0
0
7
28
2.67
1.49
1.6
1.4
—
—
—
0
0
5
16
3.29
1.46
1.2
1.6
—
—
—
0
0
5
16
3.29
1.46
1.0
1.4
13.30
14.09
ug/l
—
5
16
5
16
3.29
1.46
8.8
3.8
—
—
—
0
0
11
54
2.24
1.42
1.4
1.4
—
—
—
0
0
6
23
2.76
1.40
2.2
1.5
96.67
85.00
%
—
6
23
16
93
1.94
1.36
2.3
1.7
—
—
—
0
0
6
24
2.64
1.33
3.2
1.5
—
—
—
0
0
6
25
2.53
1.27
4.2
1.9
—
—
—
0
0
20
128
1.80
1.27
3.7
3.9
25.60
318.31
ng/l
0.85
15
108
8
38
2.25
1.23
7.1
3.6
23.75
23.82
mmol/l
—
8
38
12
70
1.87
1.00
6.1
4.0
—
—
—
0
0
12
70
1.87
1.00
9.7
19.4
119.92
123.73
g/l
0.32
12
70
30
227
1.58
1.00
2.3
2.1
1.44
1.42
mmol/l
0.02
25
187
25
187
1.53
0.85
2.0
1.7
20.28
18.87
nmol/l
0.17
20
149
52
455
1.61
0.85
6.1
5.4
3.08
3.02
ug/l
0.01
46
411
34
273
1.49
0.83
4.9
4.1
33.67
46.38
ng/l
0.45
26
213
7
43
1.70
0.69
2.0
1.3
—
—
—
0
0
6
39
1.59
0.54
9.0
2.2
1.23
1.24
%
—
6
39
60
560
1.61
0.51
41.6
20.0
37.36
26.85
mg/l
0.75
53
489
7
49
1.48
0.47
7.9
4.8
1.22
1.21
mmol/l
—
7
42
14
107
1.39
0.41
7.1
8.9
102.43
103.70
mmol/l
0.69
14
107
57
539
1.36
0.33
37.3
19.2
75.33
78.59
ml/min/173m2
0.51
52
503
10
75
1.39
0.32
1.9
1.8
1.58
1.91
%
—
10
62
8
65
1.26
0.28
2.5
2.6
11.19
9.58
ug/l
—
8
56
56
534
1.28
0.25
6.1
4.7
1.48
1.34
mmol/l
0.34
50
495
53
505
1.22
0.22
6.2
4.1
1.73
2.03
mu/l
1.02
48
449
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
57
550
1.22
0.18
6.8
5.4
1.26
1.29
mmol/l
0.25
52
511
19
175
1.12
0.10
4.1
3.3
0.00
0.42
estimate
—
6
59
7
64
1.10
0.08
1.9
1.3
—
—
—
0
0
7
65
1.09
0.08
10.0
8.4
—
—
—
0
0
25
236
1.09
0.08
9.0
4.6
12.46
11.54
mg/mmol
0.04
16
169
28
272
1.05
0.02
4.2
3.2
0.52
0.85
ug/l
1.53
22
184
24
237
1.02
0.00
4.7
3.5
0.00
0.00
estimate
—
6
60
36
365
0.97
0.00
4.8
4.6
19.98
21.97
%
0.30
17
186
19
194
0.97
0.00
5.4
3.4
0.00
0.00
estimate
—
6
65
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.8
—
0.40
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_PENIS – Carcinoma in situ of penis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).